Objectives
To investigate the effect of interleukin-1β (IL-1β) on osteogenic protein-1 (OP-1) signaling in human adult articular chondrocytes. We examined two major receptor-activated Smad (R-Smad) signaling pathways, the BMP and MAPK, in the model of IL-1β-induced cartilage degeneration.
Methods
Ankle chondrocytes from 26 normal human donors were cultured in high density monolayers in a serum-free media. Effect of IL-1β on BMP receptors was studied by RT-PCR and flow cytometry. Phosphorylation of R-Smads was tested in cells treated with IL-1β (10ng/ml), OP-1 (100ng/ml) or combined IL-1β and OP-1. Cell lysates were analyzed by Western blots with polyclonal antibodies against two R-Smads phosphorylated sites (BMP and MAPK) or total, non-phosphorylated R-Smad as a control. To identify through which MAPK IL-1β activates linker region, chondrocytes were pre-incubated with specific MAPK inhibitors (PD98059 for MAP/ERK; SP600125 for JNK; and SB203580 for p38).
Results
We found that IL-1β reduced the number of ALK-2 and ALK-3 receptors, inhibited Smad1 and Smad6 expression, delayed and prematurely terminated the onset of OP-1 mediated R-Smad phosphorylation and affected nuclear translocation of R-Smad/Smad4 complexes. We discovered that the alternative phosphorylation of R-Smad in the linker region via the MAPK pathway (primarily p38 and JNK) could be a possible mechanism through which IL-1β offsets OP-1 signaling and responses to OP-1. Conversely, OP-1 was found to directly inhibit phosphorylation of p38.
Conclusions
Our findings describe new mechanisms of the cross-talk between OP-1 and IL-1β in chondrocytes. The study also identifies potential targets for therapeutic interventions in the treatment of cartilage degenerative processes.